EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pharmacokinetics of Tylvalosin Following Intravenous or Oral Administration at Different Doses in Broiler Chickens

Zeyu Wen iD, Sumeng Chen, Jinyan Meng, Qinyao Wu, Runlin Yu, Nuoyu Xu, Jingyuan Kong iD, Lu Zhang, Xingyuan Cao iD

Veterinary Sciences · 02.02.2025 · 12 (2) · 118

DOI: 10.3390/vetsci12020118 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Veterinary Sciences, online erschienen am 02.02.2025. Verfasst von Zeyu Wen und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China. Die Arbeit wurde bisher 5-mal zitiert (Crossref) und nennt 41 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Key Research and Development Program of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Tylvalosin is a macrolide antimicrobial with antibacterial activity against Gram-positive bacteria, some Gram-negative organisms, and mycoplasma. It is used to treat respiratory and enteric bacterial infections in swine and poultry. In this study, we aimed to investigate the pharmacokinetic changes in tylvalosin following its intravenous or oral administration at doses of 5, 10, and 25 mg/kg in broiler chickens. Forty-eight broiler chickens were included in the study. The plasma concentrations of tylvalosin were measured by using ultra-performance liquid chromatography–tandem mass spectrometry (UPLC-MS/MS), and its pharmacokinetic parameters were evaluated by using both non-compartmental and compartmental analyses. The linear mixed-effects model revealed no dose proportionality within the 5–25 mg/kg range for either administration route. Based on pharmacokinetic data from a single oral dose, this study simulated a multiple-dose regimen of tylvalosin (25 mg/kg), demonstrating that a 6-hour dosing interval reaches a steady state after the fourth dose. Furthermore, the results show that the absolute bioavailability of tylvalosin after oral administration in chickens was relatively low, with values of 5.92%, 3.56%, and 3.04% for the doses of 5, 10, and 25 mg/kg, respectively. Further studies are required to significantly improve the oral bioavailability of tylvalosin and similar compounds through formulation optimization.

Schlagwörter

Stichwörter der Autor:innen

chickenspharmacokineticstylvalosin

Autor:innen und Institutionen

  • Department of Veterinary Pharmacology and Toxicology, College of Veterinary Medicine, China Agricultural University, Beijing 100193, China.
  • Key Laboratory of Detection for Veterinary Drug Residues and Illegal Additives, Ministry of Agriculture and Rural Affairs of the People's Republic of China, Beijing 100193, China.

ORCID-Profile: Zeyu Wen, Jingyuan Kong, Xingyuan Cao

Förderung

  • National Key Research and Development Program of China

Zitieren

APA

Wen, Z., Chen, S., Meng, J., Wu, Q., Yu, R., Xu, N., Kong, J., Zhang, L., & Cao, X. (2025). Pharmacokinetics of Tylvalosin Following Intravenous or Oral Administration at Different Doses in Broiler Chickens. Veterinary Sciences, 12(2), 118. https://doi.org/10.3390/vetsci12020118

Vancouver

Wen Z, Chen S, Meng J, Wu Q, Yu R, Xu N, et al. Pharmacokinetics of Tylvalosin Following Intravenous or Oral Administration at Different Doses in Broiler Chickens. Veterinary Sciences. 2025;12(2):118. doi:10.3390/vetsci12020118

BibTeX
@article{Wen2025,
  author = {Wen, Zeyu and Chen, Sumeng and Meng, Jinyan and Wu, Qinyao and Yu, Runlin and Xu, Nuoyu and Kong, Jingyuan and Zhang, Lu and Cao, Xingyuan},
  title = {Pharmacokinetics of Tylvalosin Following Intravenous or Oral Administration at Different Doses in Broiler Chickens},
  journal = {Veterinary Sciences},
  year = {2025},
  volume = {12},
  number = {2},
  pages = {118},
  doi = {10.3390/vetsci12020118}
}
Kostenlos starten →